Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac

Conditions

• Healthy

Interventions

• BIOLOGICAL: GamTBvac vaccine
• BIOLOGICAL: placebo

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Collaborators

• [object Object]
• [object Object]